Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily ...

Hims & Hers Health (NYSE:HIMS) recently announced a partnership with Novo Nordisk to enhance obesity care access in the U.S., coinciding with a notable 24% increase in its stock price over the last ...

We recently published an article titled Why These 10 Stocks Soared Today. In this article, we are going to take a look at ...

Shares of Hims & Hers Health, Inc. (HIMS) marked their best session in nearly three months on Tuesday, surging over 23% after ...

Eli Lilly CEO David Ricks is confident that weight loss med Zepbound is gaining market share at the expense of Wegovy, even as its rival strikes deals with CVS and Hims & Hers pharmacies.

SHOPPING: PSD underwear takes your style to the next level. Bold designs and unmatched comfort for a statement that starts ...

Barron's reporters have screened for potentially attractive stocks based on a variety of metrics. Here are the stocks they have identified for investors to research further. Barron's reporters ...

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that the Company will ...

With the revelation reported by the New York Times that Army Captain Rebecca Lobach was told to turn left by not only air traffic control 15 seconds before the crash, but also her instructor Chief ...